{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29658910",
  "DateCompleted": {
    "Year": "2019",
    "Month": "06",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "06",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1097/NMD.0000000000000807"
    ],
    "Journal": {
      "ISSN": "1539-736X",
      "JournalIssue": {
        "Volume": "206",
        "Issue": "5",
        "PubDate": {
          "Year": "2018",
          "Month": "May"
        }
      },
      "Title": "The Journal of nervous and mental disease",
      "ISOAbbreviation": "J Nerv Ment Dis"
    },
    "ArticleTitle": "Metabolic Syndrome, Anxiety and Depression in a Sample of Italian Primary Care Patients.",
    "Pagination": {
      "StartPage": "316",
      "EndPage": "324",
      "MedlinePgn": "316-324"
    },
    "Abstract": {
      "AbstractText": [
        "This cross-sectional study aimed at measuring the correlation and association of anxiety, depression and comorbid anxiety-depression symptoms with metabolic syndrome (MetS) in a sample of Italian primary care patients who attended their General Practitioner clinics over a 1-month period in 2013. The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depressive symptoms. The sample was made up of 129 patients (57% women; mean age, 61 \u00b1 12 years). The prevalence of MetS varied from 40% (Adult Treatment Panel III-Revised criteria) to 48% (International Diabetes Federation criteria). The prevalence of symptoms of anxiety, depression and comorbid anxiety and depression was, respectively, 26%, 2%, and 15%. MetS (defined according to Adult Treatment Panel III-Revised criteria) was associated with comorbid anxiety-depressive symptoms (odds ratio [OR] = 3.84, 95% confidence interval [CI] = 1.26-11.71), but not with anxiety or depressive symptoms only. Out of the individual components of MetS, enlarged waist circumference was associated with anxiety symptoms (OR = 4.22, 95% CI = 1.56-11.44)."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mattei",
        "ForeName": "Giorgio",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Padula",
        "ForeName": "Maria Stella",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rioli",
        "ForeName": "Giulia",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Arginelli",
        "ForeName": "Lodovico",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bursi",
        "ForeName": "Roberto",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bursi",
        "ForeName": "Serena",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Epifani",
        "ForeName": "Antonio Matteo",
        "Initials": "AM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pingani",
        "ForeName": "Luca",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rigatelli",
        "ForeName": "Marco",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rosato",
        "ForeName": "Francesca Maria",
        "Initials": "FM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sacchetti",
        "ForeName": "Andrea",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Galeazzi",
        "ForeName": "Gian Maria",
        "Initials": "GM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ferrari",
        "ForeName": "Silvia",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Nerv Ment Dis",
    "NlmUniqueID": "0375402",
    "ISSNLinking": "0022-3018"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross-Sectional Studies"
    },
    {
      "QualifierName": [
        "complications",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Italy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "complications",
        "psychology"
      ],
      "DescriptorName": "Metabolic Syndrome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Primary Health Care"
    }
  ]
}